NewAmsterdam Pharma Company
NAMS
#4540
Rank
$1.82 B
Marketcap
$19.78
Share price
0.74%
Change (1 day)
102.51%
Change (1 year)

Revenue for NewAmsterdam Pharma Company (NAMS)

Revenue in 2024 (TTM): $33.59 Million USD

According to NewAmsterdam Pharma Company's latest financial reports the company's current revenue (TTM ) is $33.59 Million USD. In 2023 the company made a revenue of $14.09 Million USD.The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for NewAmsterdam Pharma Company from 2023 to 2024

Annual revenue

Year Revenue Change
2024 (TTM) $33.59 M138.42%
2023 $14.09 M